Literature DB >> 17532294

FBXL5 interacts with p150Glued and regulates its ubiquitination.

Ning Zhang1, Jing Liu, Xia Ding, Felix Aikhionbare, Changjiang Jin, Xuebiao Yao.   

Abstract

The microtubule motor cytoplasmic dynein and its activator dynactin drive vesicular transport and mitotic spindle organization. p150(Glued) is the dynactin subunit responsible for binding to dynein and microtubules. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which governs phosphorylation-dependent ubiquitination and subsequent proteolysis. Our recent study showed that the proteolysis of mitotic kinesin CENP-E is mediated by SCF via a direct Skp1 link [D. Liu, N. Zhang, J. Du, X. Cai, M. Zhu, C. Jin, Z. Dou, C. Feng, Y. Yang, L. Liu, K. Takeyasu, W. Xie, X. Yao, Interaction of Skp1 with CENP-E at the midbody is essential for cytokinesis, Biochem. Biophys. Res. Commun. 345 (2006) 394-402]. Here we show that F-box protein FBXL5 interacts with p150(Glued) and orchestrates its turnover via ubiquitination. FBXL5 binds to p150(Glued)in vitro and in vivo. FBXL5 and p150(Glued) co-localize primarily in the cytoplasm with peri-nuclear enrichment in HeLa cells. Overexpression of FBXL5 promotes poly-ubiquitination of p150(Glued) and protein turnover of p150(Glued). Our findings provide a potential mechanism by which p150(Glued) protein function is regulated by SCFs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532294     DOI: 10.1016/j.bbrc.2007.05.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Novel strategies to enforce an epithelial phenotype in mesenchymal cells.

Authors:  Ana-Maria Dragoi; Rachel Swiss; Beile Gao; Hervé Agaisse
Journal:  Cancer Res       Date:  2014-05-20       Impact factor: 12.701

Review 2.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

Review 3.  Protein degradation and iron homeostasis.

Authors:  Joel W Thompson; Richard K Bruick
Journal:  Biochim Biophys Acta       Date:  2012-02-10

Review 4.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

5.  An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis.

Authors:  Ameen A Salahudeen; Joel W Thompson; Julio C Ruiz; He-Wen Ma; Lisa N Kinch; Qiming Li; Nick V Grishin; Richard K Bruick
Journal:  Science       Date:  2009-09-17       Impact factor: 47.728

6.  Autophagy and Ubiquitin-Proteasome System Coordinate to Regulate the Protein Quality Control of Neurodegenerative Disease-Associated DCTN1.

Authors:  Nana Wang; Qilian Ma; Panpan Peng; Yunhao Yu; Shiqiang Xu; Guanghui Wang; Zheng Ying; Hongfeng Wang
Journal:  Neurotox Res       Date:  2019-10-25       Impact factor: 3.911

7.  Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells.

Authors:  Yoshiharu Muto; Masaaki Nishiyama; Akihiro Nita; Toshiro Moroishi; Keiichi I Nakayama
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

8.  Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Authors:  Yoshiharu Muto; Toshiro Moroishi; Kazuya Ichihara; Masaaki Nishiyama; Hideyuki Shimizu; Hidetoshi Eguchi; Kyoji Moriya; Kazuhiko Koike; Koshi Mimori; Masaki Mori; Yuta Katayama; Keiichi I Nakayama
Journal:  J Exp Med       Date:  2019-03-15       Impact factor: 14.307

Review 9.  Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers.

Authors:  Yizuo Song; Min Lin; Yi Liu; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Stem Cell Res Ther       Date:  2019-04-18       Impact factor: 6.832

Review 10.  F-Box Proteins and Cancer.

Authors:  Kanae Yumimoto; Yuhei Yamauchi; Keiichi I Nakayama
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.